Enzon Pharmaceuticals, Inc. (ENZN)
0.064
-0.01
(-10.86%)
USD |
OTCM |
Feb 13, 09:39
Enzon Pharmaceuticals Cash from Financing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Agenus, Inc. | 6.683M |
| Curis, Inc. | 4.482M |
| LadRx Corp. | 0.00 |
| Plus Therapeutics, Inc. | 12.31M |
| Windtree Therapeutics, Inc. | 7.063M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.038M |
| Free Cash Flow | -2.102M |
| Free Cash Flow Per Share (Quarterly) | -0.014 |
| Free Cash Flow to Equity (Quarterly) | -1.038M |
| Free Cash Flow to Firm (Quarterly) | -1.038M |
| Free Cash Flow Yield | -44.25% |